BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17352224)

  • 1. Overexpression of human X-box binding protein 1 (XBP-1) in colorectal adenomas and adenocarcinomas.
    Fujimoto T; Yoshimatsu K; Watanabe K; Yokomizo H; Otani T; Matsumoto A; Osawa G; Onda M; Ogawa K
    Anticancer Res; 2007; 27(1A):127-31. PubMed ID: 17352224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation and overexpression of human X-box binding protein 1 (hXBP-1) gene in primary breast cancers.
    Fujimoto T; Onda M; Nagai H; Nagahata T; Ogawa K; Emi M
    Breast Cancer; 2003; 10(4):301-6. PubMed ID: 14634507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
    Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
    Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-box binding protein 1 (XBP-1) enhances colorectal cancer cell invasion.
    Mhaidat NM; Alzoubi KH; Abushbak A
    J Chemother; 2015 Jun; 27(3):167-73. PubMed ID: 25692573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and splicing of the unfolded protein response gene XBP-1 are significantly associated with clinical outcome of endocrine-treated breast cancer.
    Davies MP; Barraclough DL; Stewart C; Joyce KA; Eccles RM; Barraclough R; Rudland PS; Sibson DR
    Int J Cancer; 2008 Jul; 123(1):85-8. PubMed ID: 18386815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Met/HGF receptor modulates bcl-w expression and inhibits apoptosis in human colorectal cancers.
    Kitamura S; Kondo S; Shinomura Y; Kanayama S; Miyazaki Y; Kiyohara T; Hiraoka S; Matsuzawa Y
    Br J Cancer; 2000 Sep; 83(5):668-73. PubMed ID: 10944610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin.
    Wang HL; Wang J; Xiao SY; Haydon R; Stoiber D; He TC; Bissonnette M; Hart J
    Int J Cancer; 2002 Oct; 101(4):301-10. PubMed ID: 12209953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance.
    Zhang Z; Wang Q; Li P; Zhou Y; Li S; Yi W; Chen A; Kong P; Hu C
    Cancer Epidemiol; 2009 Aug; 33(2):130-6. PubMed ID: 19679060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
    Alqurashi N; Gopalan V; Smith RA; Lam AK
    Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
    Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
    Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
    BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
    Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
    Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel gene containing PDZ and LIM domains, PCD1, is overexpressed in human colorectal cancer.
    Furuya M; Tsuji N; Endoh T; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
    Anticancer Res; 2002; 22(6C):4183-6. PubMed ID: 12553053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
    Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
    BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation.
    Ropponen KM; Kellokoski JK; Pirinen RT; Moisio KI; Eskelinen MJ; Alhava EM; Kosma VM
    J Clin Pathol; 2001 Jul; 54(7):533-8. PubMed ID: 11429425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of GAEC1 mRNA and protein and its association with clinical and pathological parameters of patients with colorectal adenocarcinoma.
    Wahab R; Gopalan V; Islam F; Mamoori A; Lee KT; Lu CT; Lam AK
    Exp Mol Pathol; 2018 Feb; 104(1):71-75. PubMed ID: 29337242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.